| Characteristic . | Control never-smokers . | Control ex-smokers . | COPD ex-smokers . |
|---|---|---|---|
| Subjects (n) | 8 | 10 | 11 |
| Men/women | 0/8 | 8/2a | 8/3a |
| Age (yr) | 71.1 ± 6.6 | 69.0 ± 10.2 | 70.1 ± 7.7 |
| Smoking (pack/yr) | 0.0 ± 0.0 | 37.5 ± 27.2a | 53.2 ± 33.1b |
| FVC (% of predicted) | 106.1 ± 15.6 | 105.0 ± 11.7 | 106.0 ± 13.4 |
| FEV1 (% of predicted) | 108.4 ± 16.0 | 114.1 ± 20.2 | 75.5 ± 14.9a,c |
| FEV1/FVC (%) | 78.3 ± 7.0 | 81.1 ± 8.0 | 55.7 ± 10.2a,c |
| GOLD (I/II/III/IV) | 4/7/0/0 |
| Characteristic . | Control never-smokers . | Control ex-smokers . | COPD ex-smokers . |
|---|---|---|---|
| Subjects (n) | 8 | 10 | 11 |
| Men/women | 0/8 | 8/2a | 8/3a |
| Age (yr) | 71.1 ± 6.6 | 69.0 ± 10.2 | 70.1 ± 7.7 |
| Smoking (pack/yr) | 0.0 ± 0.0 | 37.5 ± 27.2a | 53.2 ± 33.1b |
| FVC (% of predicted) | 106.1 ± 15.6 | 105.0 ± 11.7 | 106.0 ± 13.4 |
| FEV1 (% of predicted) | 108.4 ± 16.0 | 114.1 ± 20.2 | 75.5 ± 14.9a,c |
| FEV1/FVC (%) | 78.3 ± 7.0 | 81.1 ± 8.0 | 55.7 ± 10.2a,c |
| GOLD (I/II/III/IV) | 4/7/0/0 |